Sparsity-based Magnetic Resonance Imaging of Cardiac Arrhythmias

NYU Langone Health135 enrolled

Overview

The primary purpose of this study is to improve the quality of Magnetic Resonance Imaging in patients with heart arrhythmia. Investigators will recruit 105 patients with arrhythmia and 30 control volunteers over 3 years and will use two arrhythmia-tolerant imaging methods for diagnosis.

In the proposed research, investigators will extend conventional cardiac magnetic resonance methods to enable the creation of high-quality cine CMR images in the presence of multiple kinds of arrhythmia. Two arrhythmia-tolerant imaging methods will be adopted, which are particularly useful in arrhythmia: 1) 3D imaging, which is useful for many purposes, including "road mapping" of electrophysiology (EP) procedures, and 2) late gadolinium enhancement (LGE), which is useful for delineating abnormal myocardium, including fibrotic regions that can serve as sources of arrhythmias.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

135

Conditions

Cardiac Arrythmias

Interventions

3D ImagingOTHER

"roadmapping" of electrophysiology (EP) procedures

Late Gadolinium Enhancement (LGE)OTHER

useful for delineating abnormal myocardium, including fibrotic regions that can serve as sources of arrhythmias.

Eligibility

Sex: ALLMin age: 10 YearsMax age: 85 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria for Arrhythmia Patients: * Patients diagnosed with heart arrhythmia scheduled for routine clinical MRI examinations). * Patients scheduled for routine clinical MRI examinations who do not have a specific known diagnosis of arrhythmia, but who may be found to have image degradation due to arrhythmia during the CMR examination. Inclusion Criteria for Controls: * No history of heart arrhythmia. Exclusion Criteria for Patients and Controls: * Hemodynamic instability. * Contraindications for MRI examinations (e.g., pacemakers or ferromagnetic vascular clips). * History of prior cardiovascular disease or significant risk factors: * Diabetes, hypertension, smoking, and hyperlipidemia, etc.

Locations (1)

New York University School of Medicine

New York, New York, United States

Outcomes

Primary Outcomes

Paired-sample Wilcoxon signed rank test to evaluate measures on Likert scales

Time frame: 3 Years

Paired-sample t tests for quantitative measures of intensity of image artifacts

Time frame: 3 Years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.